about
Examining the pathogenesis of breast cancer using a novel agent-based model of mammary ductal epithelium dynamicsInvasive cribriform carcinoma of the breast: A report of nine cases and a review of the literatureLobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapyInvasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes.The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype.Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study.Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial.Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers.Invasive cribriform carcinoma in a Chinese population: comparison with low-grade invasive ductal carcinoma-not otherwise specified.The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches.Neoadjuvant tamoxifen synchronizes ERα binding and gene expression profiles related to outcome and proliferation.Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen responseLuminal breast cancer: from biology to treatment.Optimal adjuvant chemotherapy in breast cancer: selection of agents.Issues Affecting the Loco-regional and Systemic Management of Patients with Invasive Lobular Carcinoma of the Breast.Treatment choices for patients with invasive lobular breast cancer: a doctor survey.An Analysis of Oncotype DX Recurrence Scores and Clinicopathologic Characteristics in Invasive Lobular Breast Cancer.Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.Mixed invasive ductal and lobular carcinoma has distinct clinical features and predicts worse prognosis when stratified by estrogen receptor status.Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights.Oncogenic PIK3CA mutations in lobular breast cancer progression.Invasive breast cancer: a significant correlation between histological types and molecular subgroups.Clinicopathological characteristics and survival outcomes of invasive lobular carcinoma in different races.The clinical relevance of micropapillary carcinoma of the breast: a case-control study.Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities.[Invasive breast cancer: the current WHO classification].Differential expression and clinical significance of epithelial-mesenchymal transition markers among different histological types of triple-negative breast cancer.Omission of Postoperative Radiotherapy in Women Aged 65 Years or Older With Tubular Carcinoma of the Breast After Breast-Conserving Surgery.
P2860
Q28383242-48A5D64F-3CA5-43DE-8BCA-47B2AF94F505Q30416537-15E5CF56-235D-4DFE-804F-3BDDB93AA54DQ34537257-F3506C88-928B-4083-8E1B-D90485598BA5Q35086250-66F220D8-8B2E-4777-A08C-9A0D0B4FCE33Q35219157-69DC2C0D-E2EE-4949-A9A3-90CFB42DA0AAQ36194648-B50EE452-2635-4BCD-B45C-85A8092BA0D5Q36316636-3E38D721-BE97-4352-B836-B26D5E8FD935Q36547888-BEA79693-BCF5-4181-B128-EBFEEE2181A9Q36584362-DDB39ADE-A014-4F55-AB4A-ACA63A4FA805Q37301836-47D6D03B-D883-4C13-AC0D-C97BCBD5C462Q37376167-9523A977-F177-4922-8AD4-B6A0A2037352Q37639160-E34666A0-A202-41F9-B0C3-B2AFEC9A7C69Q38123680-46E2024C-3A7D-491F-9321-BFEEDF33ADD0Q38235713-74ADDF04-8AA5-4178-9F9B-CDBE7EBFB77AQ38702293-F0999DA2-BD5D-4880-AE06-B36A0343FFBDQ38997433-0E9F555E-2CAC-49D1-AFCD-080AE461497BQ39015485-206D7D84-8952-442D-B5E0-C6909EBC2686Q39703687-2E62C424-1148-4B8C-AF4B-EA47C6DCD4A0Q41169486-936D5EB5-F7FE-4E06-915F-CF3F954C7478Q41605699-AAF5DC07-3A05-4839-A7AE-9638A0361BE3Q42473382-779BA0DA-7AA3-421E-9E2E-F03250302E32Q42513022-7538125B-AFA9-43DD-8896-D7C659B4392EQ42518349-5830F40A-48BE-492B-A335-D07463B9DDD5Q43514504-666952B1-DA98-46FB-8F2E-3132636A730DQ45248615-BE7FB3BC-6760-4ADA-B882-27E5932A4CFBQ46311036-A3786981-3C63-4540-BAAD-1FF19B1B0642Q48610007-CC7B9A3C-35C1-4C7D-90C9-7332241D7A3AQ50352878-E057BEBF-32F3-42DB-9FC5-4FBE1BE5418FQ55025978-49CC3166-4ADF-47C9-BFA3-0B792935B499
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Outcome of special types of luminal breast cancer.
@en
Outcome of special types of luminal breast cancer.
@nl
type
label
Outcome of special types of luminal breast cancer.
@en
Outcome of special types of luminal breast cancer.
@nl
prefLabel
Outcome of special types of luminal breast cancer.
@en
Outcome of special types of luminal breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Outcome of special types of luminal breast cancer.
@en
P2093
A Cardillo
A Goldhirsch
E Montagna
G Cancello
M Colleoni
M G Mastropasqua
P2860
P304
P356
10.1093/ANNONC/MDR461
P577
2011-10-29T00:00:00Z